ANNUAL GLOBAL SURVEY 2011 - World Federation of Hemophilia
ANNUAL GLOBAL SURVEY 2011 - World Federation of Hemophilia
ANNUAL GLOBAL SURVEY 2011 - World Federation of Hemophilia
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>World</strong> <strong>Federation</strong> <strong>of</strong> <strong>Hemophilia</strong> Global Survey <strong>2011</strong>8. Number <strong>of</strong> identified people with hemophilia by diagnosis <strong>of</strong> severityType <strong>of</strong> hemophiliaMild(factor levelabove 5%)Moderate(factor level1% to %5)Severe(factor levelbelow 1%)SeverityunknownNoData<strong>Hemophilia</strong> A male<strong>Hemophilia</strong> A female<strong>Hemophilia</strong> B male<strong>Hemophilia</strong> B female9. Number <strong>of</strong> severe VWD patientsTotal number <strong>of</strong>severe (type 3)VWD patientsNumber <strong>of</strong> VWD patientsreceiving replacementtherapyNumber <strong>of</strong> VWD patientswith severe bleedingsymptomsNoData10. INHIBITORS: Number <strong>of</strong> identified people with hemophilia with current clinically significantinhibitors. (Patients who do not respond to normal treatment.)Type <strong>of</strong> hemophilia Number with current inhibitors NoData<strong>Hemophilia</strong> A<strong>Hemophilia</strong> B11. Products used to treat hemophilia: What percentage <strong>of</strong> patients is treated with the followingproducts?Plasma %Cryoprecipitate %Plasma-derived concentrate %Recombinant concentrate %DDAVP (Desmopressin) %12. Products used to treat vWD: What percentage <strong>of</strong> patients is treated with the followingproducts?Plasma %Cryoprecipitate %Plasma-derived concentrate %DDAVP (Desmopressin) %13. HIV and hepatitis C infection among living people with hemophiliaInfectiousDiseaseHIVHepatitis CNumber <strong>of</strong> people infected Percentage <strong>of</strong> people tested NoDataWFH Global Survey <strong>2011</strong> 34
Change language